N1-((1-(1H-BENZIMIDAZOL-2-YLMETHYL)-1H-BENZIMIDAZOL-2-YL)METHYL)-N1-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-1,4-BUTANEDIAMINE
UNII JX7WH7ZLE5
Substance Identification & Data
This profile provides standardized clinical and technical data for N1-((1-(1h-benzimidazol-2-ylmethyl)-1h-benzimidazol-2-yl)methyl)-n1-((8s)-5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JX7WH7ZLE5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2409847-43-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H33N7 QPPMVBFZIURBHN-SANMLTNESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N1-((1-(1h-benzimidazol-2-ylmethyl)-1h-benzimidazol-2-yl)methyl)-n1-((8s)-5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.